Endpoints in Heart Failure Drug Development

Heart failure (HF) is a major health problem worldwide. The development of effective drug and/or device therapy is crucial to mitigate the significant morbidity, mortality and healthcare costs associated with HF. The choice of endpoint in clinical trials has important practical and clinical implicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Aliza, Misra, Arunima, Bozkurt, Biykem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2022
Materias:
Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790723/
https://www.ncbi.nlm.nih.gov/pubmed/35111335
http://dx.doi.org/10.15420/cfr.2021.13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790723/
https://www.ncbi.nlm.nih.gov/pubmed/35111335
http://dx.doi.org/10.15420/cfr.2021.13

Ejemplares similares